Nov 11, 2024 6:19 AM
BACK TO TOP
KSE100
93,291.68
771.20
(0.83%)
ALLSHR
59,401.09
530.35
(0.90%)
KSE30
29,016.96
255.08
(0.89%)
KMI30
142,361.27
1501.91
(1.07%)
BKTI
21,535.55
-118.71
(-0.55%)
OGTI
22,759.07
469.82
(2.11%)
KMIALLSHR
40,891.16
309.36
(0.76%)
PSXDIV20
36,437.18
384.37
(1.07%)
UPP9
28,054.38
54.43
(0.19%)
NITPGI
22,527.27
144.36
(0.64%)
NBPPGI
25,445.82
229.09
(0.91%)
MZNPI
18,870.26
232.97
(1.25%)
JSMFI
27,189.98
1058.75
(4.05%)
ACI
14,793.04
138.38
(0.94%)
JSGBKTI
24,142.19
-95.06
(-0.39%)
MII30
13,382.14
149.62
(1.13%)
HBLTTI
15,183.43
01-11-2024
8.25
(0.05%)
BF Biosciences Limited
PHARMACEUTICALS
Rs.94.73
0.40
(0.42%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Fri, Nov 8, 2024 5:09 PM
REG
FUT
ODL
Open
94.00
High
95.00
Low
93.00
Volume
220,796
CIRCUIT BREAKER
84.90 — 103.76
DAY RANGE
93.00 — 95.00
52-WEEK RANGE
74.55 — 98.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
94.33
VAR
25.00
HAIRCUT
32.50
P/E Ratio (TTM) **
N/A
1-Year Change *
0.42%
YTD Change *
0.42%

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

BF Biosciences Limited ("BFBL", "Company", or the "Issuer") was incorporated as an unlisted public limited company under the Companies Ordinance, 1984 (now Companies Act, 2017) in 2006, and operates within the pharmaceutical industry. BFBL is a 80%:20% joint venture between Ferozsons Laboratories Limited and the Bagó Group of Argentina. The Company's core operations involve the import, manufacturing, marketing and distribution of pharmaceutical products.

KEY PEOPLE
Akhter Khalid WaheedCEO
Sebastian Martin FerrarassiChairperson
Abdur RehmanCompany Secretary
ADDRESS

197-A, The Mall, Rawalpindi, Pakistan

WEBSITE

www.bfbio.com

REGISTRAR

CDC Share Registrar Services Limited, CDC House, 99-B, Block-B, S.M.C.H.S, Main Shahrah Faisal, Karachi

AUDITOR

KPMG Taseer Hadi & Co. Chartered Accountants

Equity Profile

Market Cap (000's)
8,367,816.73
Shares
88,333,334
Free Float
26,500,000
Free Float
30.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 30, 2024Transmission of Quarterly Report for the Period Ended 2024-09-30 View   PDF
Oct 28, 2024Financial Results for the Quarter Ended 2024-09-30 View   PDF
Oct 25, 2024Transmission of Annual Report for the Year Ended 2024-06-30 View   PDF
DateTitleDocument
Oct 28, 2024Certified true copy of the resolutions passed in the Annual General Meeting of the Company View   PDF
Oct 25, 2024Notice of Annual General Meeting View   PDF
Oct 23, 2024Board Meeting View   
DateTitleDocument

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
No Data Available
No Data Available
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Payouts

Financial Reports